Publication:
120-W GreenLight Laser Photoselective Vaporization of Prostate for Benign Prostatic Hyperplasia: Midterm Outcomes

dc.contributor.authorTasci, Ali Ihsan
dc.contributor.authorİLBEY, YUSUF ÖZLEM
dc.contributor.authorLuleci, Huseyin
dc.contributor.authorCicekler, Olcay
dc.contributor.authorSahin, Selcuk
dc.contributor.authorÇEVİK, CEM
dc.contributor.authorTugcu, Volkan
dc.contributor.institutionauthorİLBEY, YUSUF ÖZLEM
dc.date.accessioned2022-01-27T21:00:18Z
dc.date.available2022-01-27T21:00:18Z
dc.date.issued2011-07-01T00:00:00Z
dc.description.abstractOBJECTIVES To evaluate the safety and efficacy of 120-W high-performance system (HPS) laser photoselective vaporization of the prostate (PVP) in the treatment of patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia.
dc.identifier.citationTasci A. I. , İLBEY Y. Ö. , Luleci H., Cicekler O., Sahin S., ÇEVİK C., Tugcu V., -120-W GreenLight Laser Photoselective Vaporization of Prostate for Benign Prostatic Hyperplasia: Midterm Outcomes-, UROLOGY, cilt.78, sa.1, ss.134-140, 2011
dc.identifier.doi10.1016/j.urology.2010.12.085
dc.identifier.scopus79959698419
dc.identifier.urihttp://hdl.handle.net/20.500.12645/30338
dc.identifier.wosWOS:000292080300033
dc.title120-W GreenLight Laser Photoselective Vaporization of Prostate for Benign Prostatic Hyperplasia: Midterm Outcomes
dc.typeArticle
dspace.entity.typePublication
local.avesis.idce33af39-1132-42b5-882a-0d654d67429d
local.publication.isinternational1
relation.isAuthorOfPublicatione166fdca-de94-48b0-a771-14053e70c6ca
relation.isAuthorOfPublication.latestForDiscoverye166fdca-de94-48b0-a771-14053e70c6ca
Files